# Emphysematous gastritis with portal venous gas: conservative management in a high-risk patient

**Authors:** Sandeepa Dadigamuwage, Vimarshini Samarakoon, Emma Horrocks

PMC · DOI: 10.1093/jscr/rjag089 · Journal of Surgical Case Reports · 2026-02-27

## TL;DR

A high-risk patient with emphysematous gastritis was successfully managed without surgery, but later died from unrelated complications.

## Contribution

This case report demonstrates successful conservative treatment of emphysematous gastritis in a high-risk patient.

## Key findings

- Non-operative management led to complete radiological resolution of emphysematous gastritis.
- The patient later developed sepsis from a pressure ulcer and transitioned to palliative care.
- Conservative treatment can be considered in high-risk patients with this rare condition.

## Abstract

Emphysematous gastritis is a rare, often fatal condition characterized by gas within the gastric wall, usually in patients with significant comorbidities. We describe a 75-year-old man with incomplete tetraparesis, chronic respiratory failure and type 2 diabetes who presented with abdominal pain, vomiting and hematemesis. Initial computed tomography (CT) was reported as non-obstructive small-bowel dilatation with possible gallstone ileus, but subspecialty radiology review identified intramural gastric gas with portal venous gas consistent with emphysematous gastritis. He was managed non-operatively with nasogastric decompression, intravenous broad-spectrum antibiotics and proton-pump inhibition within a ward-based ceiling of care. Repeat CT on day 10 showed complete radiological resolution. Despite this, he later developed sepsis from a large necrotic pressure ulcer and died after a multidisciplinary decision for palliative care. This case supports conservative management in selected high-risk patients and emphasizes early, meticulous pressure-area assessment in immobile surgical admissions.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** necrosis (MESH:D009336), Emphysematous gastritis (MESH:D005756), sepsis (MESH:D018805), spinal injury (MESH:D013124), mucosal injury (MESH:D052016), aspiration pneumonia (MESH:D011015), obstructive sleep apnea (MESH:D020181), type 2 diabetes (MESH:D003924), gastric (MESH:D013272), sacral osteomyelitis (MESH:D010019), gallstone ileus (MESH:D045823), bipolar disorder (MESH:D001714), ischemic heart disease (MESH:D017202), peritonitis (MESH:D010538), infection (MESH:D007239), volvulus (MESH:D045822), pressure injuries (MESH:D003668), sphenoid meningioma (MESH:D008579), death (MESH:D003643), fevers (MESH:D005334), pulmonary embolism (MESH:D011655), vomiting (MESH:D014839), nausea (MESH:D009325), chronic respiratory failure (MESH:D012131), hematemesis (MESH:D006396), tetraparesis (MESH:C565722), diabetes (MESH:D003920), benign gastric emphysema (MESH:D004646), abdominal pain (MESH:D015746), large-bowel obstruction (MESH:D012778), inflammatory (MESH:D007249)
- **Chemicals:** gabapentin (MESH:D000077206), hydrogen (MESH:D006859), rosuvastatin (MESH:D000068718), carbon dioxide (MESH:D002245), Piperacillin-tazobactam (MESH:D000077725), baclofen (MESH:D001418), olanzapine (MESH:D000077152), metformin (MESH:D008687), clindamycin (MESH:D002981), amoxicillin-clavulanate (MESH:D019980), metronidazole (MESH:D008795), tizanidine (MESH:C023754), teicoplanin (MESH:D017334), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947788/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12947788/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947788/full.md

---
Source: https://tomesphere.com/paper/PMC12947788